Exo Secures $40 Million Funding For Its New Ultrasound Device

Exo, an Indian-American based startup has raised a fund of $40 Million in the Series B funding round. The company announced that the funding will be used for research and development of its new handheld medical device and cloud-based software platform.

The company is now working on medical imaging technology which would help physicians and healthcare workers all around the world.

Their new handheld ultrasound device can be used for creating a quality image that would serve as a powerful diagnostic tool in the medical industry.

“Emergency room physicians around the world are often tasked with solving some of the most urgent healthcare problems — COVID-19 diagnosis and complications, cardiac emergencies, internal bleeding — without being able to see clearly into a patient they only have minutes to diagnose and treat,” said Sandeep Akkaraju, CEO and Co-Founder of Exo.

He also added, “Exo plans to give these critical frontline heroes the device they need — one that immediately opens up a window into everybody and enables them to make speedy, accurate and often life-saving medical decisions on the spot.”

It is also believed that it will be a revolutionary invention in the medical especially during these tough times. The device would cost-effective and easily accessible with a workflow app so that it could be carried in the pocket by every healthcare worker and also to diagnose chronic issues in the hospitals. Companies like Fiscus Ventures, Reimagined Ventures, TDK Ventures, Solasta Ventures and Action Potential Venture Capital are some of the key investors of Exo.